Clinical and Pathophysiological Description of Ocular Ischemic Syndrome

NCT00403195 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2012-09-10

No results posted yet for this study

Summary

The purpose of this study is to characterize the disease Ocular Ischemic Syndrome.

Conditions

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER
  • University Hospital, Gentofte, Copenhagen

    collaborator OTHER
  • Glostrup University Hospital, Copenhagen

    lead OTHER

Principal Investigators

  • Michael Larsen, Professor

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00403195 on ClinicalTrials.gov